Publication | Closed Access

Scutellarin synergistically enhances cisplatin effect against ovarian cancer cells through enhancing the ability of cisplatin binding to DNA

ChromatinChromatin RemodelingMedicineCisplatin BindingAnti-cancer AgentTumor SuppressorCisplatin EffectCancer TreatmentRadiation OncologyCancer BiologyCell BiologyTumor BiologyOvarian CancerOvarian Cancer Cells